PE Weekly: Dealmakers Turn to Healthcare in a Slow Week for M&A
Middle-market dealmakers close out May with a slow week for M&A, but healthcare finishes the month strong
Healthcare
Thematic Investing Brings PE to the Clinical Trials Market
COVID-19 shone a light on a fragmented market. Now private equity firms are building platforms of clinical site businesses with an eye toward improving diversity.
Navigating Human Capital Challenges in Healthcare M&A
Insperity and Medaxion discuss their collaboration on seamless healthcare rollups
Scaling Physician Practices to Increase Value
Fulcrum Equity Partners' Chad Hooker discusses how to strengthen the relationship between physician practices and growth equity investors
Finding Value in Healthcare
Value-based care and healthcare IT continued to draw investors in the first quarter of 2022, as companies and sponsors work to build bigger platforms
Six Macro Trends Shaping Healthcare M&A
Industry changes translate into investment opportunities
Pioneering Life Science M&A with Cloud-Based Technology
A look at how cloud models are replacing cost-intensive legacy systems with a more flexible, subscription-based operating model.
Sounds Like a Plan
McGriff drives healthcare cost reductions for mid-market employers through a strategic platform.
Leveraging Insurance Captives to Better Manage Employee Health Plan Costs in the Wake of COVID-19
The pandemic will likely accelerate health care costs, pushing many companies to self-insure and adopt other cost-saving strategies.
Envisioning the Future of Health Care
Health care and investment industry leaders delved into emerging opportunities in pharma and life sciences during two recent virtual sessions presented by ACG.